Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches.
暂无分享,去创建一个
Chindo Hicks | Deepali Bhandari | U. Lendahl | K. Siziopikou | K. Albain | A. Marchese | K. Yao | C. Osipo | C. Hicks | L. Miele | B. Nickoloff | P. Rizzo | Kathy Albain | Haixi Miao | D. Tonetti | Jieun Yun | Lucio Miele | Huiping Zhao | J. Qin | Urban Lendahl | J. Yun | P. Rajan | Brian J Nickoloff | Huiping Zhao | Clodia Osipo | Jian-Zhong Qin | Kalliopi Siziopikou | S. Selvaggi | Joaquina Mascarenhas | Paola Rizzo | Gwendolyn D'Souza | Lynda L Song | Debra Wyatt | Giovanni Antico | Lu Hao | Katharine Yao | Prabha Rajan | Suzanne Selvaggi | Amina Bashir | Adriano Marchese | Debra A Tonetti | G. Antico | Deepali Bhandari | H. Miao | D. Wyatt | L. Song | J. Mascarenhas | A. Bashir | L. Hao | G. D'Souza | Debra Wyatt | Haixi Miao
[1] M. Vooijs,et al. Ectodomain Shedding and Intramembrane Cleavage of Mammalian Notch Proteins Are Not Regulated through Oligomerization* , 2004, Journal of Biological Chemistry.
[2] A. Howell,et al. A putative human breast stem cell population is enriched for steroid receptor-positive cells. , 2005, Developmental biology.
[3] Antonio Baonza,et al. Control of cell proliferation in the Drosophila eye by Notch signaling. , 2005, Developmental cell.
[4] J. Sklar,et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles , 1996, The Journal of experimental medicine.
[5] Yan Li,et al. Regulation of Notch1 and Dll4 by Vascular Endothelial Growth Factor in Arterial Endothelial Cells: Implications for Modulating Arteriogenesis and Angiogenesis , 2003, Molecular and Cellular Biology.
[6] G. Melino,et al. E1A Activates Transcription of p73 and Noxa to Induce Apoptosis* , 2005, Journal of Biological Chemistry.
[7] P. V. van Diest,et al. Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment , 2002, British Journal of Cancer.
[8] A. Capobianco,et al. Induction of Cyclin D1 Transcription and CDK2 Activity by Notchic: Implication for Cell Cycle Disruption in Transformation by Notchic , 2001, Molecular and Cellular Biology.
[9] H. Pass,et al. Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells , 2003, Oncogene.
[10] A. Ferrando,et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia , 2007, The Journal of experimental medicine.
[11] A. Diévart,et al. Involvement of Notch1 in the development of mouse mammary tumors , 1999, Oncogene.
[12] J. Aster,et al. The multifaceted role of Notch in cancer. , 2007, Current opinion in genetics & development.
[13] A. Howell,et al. Dissociation between steroid receptor expression and cell proliferation in the human breast. , 1997, Cancer research.
[14] A. Strasser,et al. Mutually Exclusive Subsets of BH3-Only Proteins Are Activated by the p53 and c-Jun N-Terminal Kinase/c-Jun Signaling Pathways during Cortical Neuron Apoptosis Induced by Arsenite , 2005, Molecular and Cellular Biology.
[15] S. Artavanis-Tsakonas,et al. Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[16] G. Lockwood,et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. , 2005, Cancer research.
[17] B. Osborne,et al. Notch-1 Regulates NF-κB Activity in Hemopoietic Progenitor Cells1 , 2001, The Journal of Immunology.
[18] J. Russo,et al. Evidence for the notch signaling pathway on the role of estrogen in angiogenesis. , 2004, Molecular endocrinology.
[19] R. Callahan,et al. Notch Signaling in Mammary Gland Tumorigenesis , 2004, Journal of Mammary Gland Biology and Neoplasia.
[20] D. Sassoon,et al. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. , 1996, Development.
[21] U. Lendahl,et al. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. , 2007, Cancer research.
[22] W. Hahn,et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells , 2002, Nature Medicine.
[23] D. Felsher,et al. Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression. , 2005, Cancer research.
[24] U. Lendahl,et al. A Sensitive and Quantitative Assay for Measuring Cleavage of Presenilin Substrates* , 2002, The Journal of Biological Chemistry.
[25] G. Grégori,et al. Sustained Activation of p38 Mitogen-Activated Protein Kinase and c-Jun N-Terminal Kinase Pathways by Hepatitis B Virus X Protein Mediates Apoptosis via Induction of Fas/FasL and Tumor Necrosis Factor (TNF) Receptor 1/TNF-α Expression , 2004, Molecular and Cellular Biology.
[26] S. Artavanis-Tsakonas,et al. Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium. , 2004, The American journal of pathology.
[27] M. Hendrix,et al. Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. , 2005, Cancer research.
[28] U. Lendahl,et al. Constitutive activation of NF‐κB and T‐cell leukemia/lymphoma in Notch3 transgenic mice , 2000, The EMBO journal.
[29] K. Pfizenmaier,et al. Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells. , 2004, Molecular endocrinology.
[30] V. Jordan,et al. Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation. , 1996, British Journal of Cancer.
[31] Ssang-Goo Cho,et al. Notch interferes with the scaffold function of JNK-interacting protein 1 to inhibit the JNK signaling pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Aster,et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. , 2006, Genes & development.
[33] D. Ginsberg,et al. Up-regulation of Bcl-2 Homology 3 (BH3)-only Proteins by E2F1 Mediates Apoptosis* , 2004, Journal of Biological Chemistry.
[34] G. Cordell,et al. Cytotoxic and antimalarial bisbenzylisoquinoline alkaloids from Stephania erecta. , 1993, Journal of natural products.
[35] L. L. Reed,et al. Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells , 2005, Oncogene.
[36] Patrick Maisonneuve,et al. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis , 2004, The Journal of cell biology.
[37] P. Jansen-Dürr,et al. E2F target genes and cell‐cycle checkpoint control , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.
[38] T. Giordano,et al. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. , 2005, Cancer cell.
[39] R. Clarke,et al. Aberrant Activation of Notch Signaling in Human Breast Cancer , 2006 .
[40] J. Aster,et al. Notch Signaling in Cancer , 2002, Cancer biology & therapy.
[41] D. Scudiero,et al. New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.
[42] G. Lockwood,et al. High-level JAG1 mRNA and protein predict poor outcome in breast cancer , 2007, Modern Pathology.
[43] Andrew P. Weng,et al. Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.
[44] J. Nevins,et al. E2F transcription factor is a target for the RB protein and the cyclin A protein. , 1991, Cold Spring Harbor symposia on quantitative biology.
[45] Rob Pieters,et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors , 2007, The Journal of experimental medicine.
[46] S. Artavanis-Tsakonas,et al. Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2 , 1997, Molecular and cellular biology.
[47] T. Golde,et al. ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor , 2008, Oncogene.